CYP2C19 genotypes in Germany and influence on treatment of Helicobacter pylori infection

被引：2
|
作者：
Kirsch, C
Schneider-Brachert, W
Grossmann, D
Stolte, M
Lehn, N
Miehlke, S
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)80897-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A180 / A180
页数：1
相关论文
共 50 条
  • [31] Influence of CYP2C19*2, CYP2C19*3 and CYP2C9*3 genotypes on anti-epileptic drugs resistance of refractory epileptics
    Zhang Qingxia
    Jiang DeChun
    Wang YuQin
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 227P - 227P
  • [32] PHARMACOKINETICS OF TOLPERISONE IN THREE CYP2C19 GENOTYPES
    Kim, Y.
    Byeon, J.
    Lee, J.
    Kim, S.
    Lee, Y.
    Lee, Y.
    Lee, S.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 168 - 168
  • [33] Effect of genetic polymorphism of CYP2C19 on eradication of Helicobacter pylori with various triple therapies
    Yamaji, Y
    Hirata, Y
    Akanuma, M
    Mitsuno, Y
    Maeda, S
    Ogura, K
    Okamoto, M
    Yoshida, H
    Kawabe, T
    Shiratori, Y
    Omata, M
    GASTROENTEROLOGY, 2001, 120 (05) : A587 - A587
  • [34] Clinical role of CYP2C19 in the management of failed Helicobacter pylori (Hp) infected patients
    Perna, F
    Sapone, A
    Gatta, L
    Trespidi, S
    Paolini, M
    Biagi, GL
    Forti, GC
    Osborn, J
    Ricci, C
    Tampieri, A
    Miglioli, M
    Vaira, D
    GUT, 2002, 51 : A11 - A11
  • [35] The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19☆2 genotyping
    Langaee, Taimour Y.
    Zhu, Hao-Jie
    Wang, Xinwen
    El Rouby, Nihal
    Markowitz, John S.
    Goldstein, Joyce A.
    Johnson, Julie A.
    PHARMACOGENETICS AND GENOMICS, 2014, 24 (08): : 381 - 386
  • [36] The efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism:: Author's reply
    Sheu, BS
    Kao, AW
    Cheng, HC
    Hunag, SF
    Chen, TW
    Lu, CC
    Wu, JJ
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (03) : 275 - 276
  • [37] Prevalence of CYP2C19 polymorphisms in Helicobacter pylori positive (HP plus ) Greek patients
    Karagiannis, Karagiannisa.
    Lycousi, Lycousi
    Nicoletta, Mathou
    Konstantina, Paraskeva
    Athanasios, Giannakopoulos
    Fotini, Artemaki
    Katerina, Evgenidou
    Stylianos, Papasavvas
    Evangelia, Platsouka
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 65 - 65
  • [38] Impact of genotypic differences in CYP2C19 status on the eradication of Helicobacter pylori in Caucasian patients
    Schwab, M
    Schaeffeler, E
    Klotz, U
    Treiber, G
    GASTROENTEROLOGY, 2003, 124 (04) : A361 - A361
  • [39] Effects of allicin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes
    Yang, Li-Jun
    Fan, Lan
    Liu, Zhao-Qian
    Mao, Yan-Mei
    Guo, Dong
    Liu, Li-Hui
    Tan, Zhi-Rong
    Peng, Liang
    Han, Chun-Ting
    Hu, Dong-Li
    Wang, Dan
    Zhou, Hong-Hao
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (06) : 601 - 608
  • [40] Effect of glycyrrhizin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes
    Tu, J. -H.
    Hu, D. -L.
    Dai, L. -L.
    Sun, Y.
    Fan, L.
    Zhang, M.
    Tan, Z. -R.
    Chen, Y.
    Li, Z.
    Zhou, H. -H.
    XENOBIOTICA, 2010, 40 (06) : 393 - 399
12345